Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | GLA | P06280 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8476636 | 0.83 | GLA (0.43) | ALDH1A1GLATP53MAPTLMNA | |
| SCHEMBL5676152 | 0.82 | ALDH1A1 (0.48) | ALDH1A1GLATP53MAPTLMNA | |
| SCHEMBL8476269 | 0.80 | F2 (0.51) | TP53MAPTLMNA | |
| SCHEMBL8481378 | 0.79 | F2 (0.56) | — | |
| SCHEMBL5673341 | 0.78 | F2 (0.50) | ALDH1A1GLATP53MAPTSMN1; SMN2 | |
| SCHEMBL8481393 | 0.78 | F2 (0.55) | — | |
| SCHEMBL8476293 | 0.78 | F2 (0.57) | — | |
| SCHEMBL8477294 | 0.77 | F2 (0.57) | — | |
| SCHEMBL8479188 | 0.76 | F2 (0.56) | — | |
| SCHEMBL8481901 | 0.75 | F2 (0.61) | ALDH1A1MAPTLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5891909-A | Amidinohydrazones as protease inhibitors | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 1999-04-06 | — | — | US | disclosed |